Stock listing
NASDAQ:STML Stemline Therapeutics Inc Stock
Follow Stemline Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:STML
$11.83 USD
Close on Jun 11, 2020 · No longer trades
- Lowest – highest close
- $3.41 – $47.13 USDSince Jan 28, 2013 · lowest Mar 18, 2020 · highest Oct 1, 2013
Delisted NASDAQ:STML no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:STML
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Stemline Therapeutics Inc on 6ix
- Decks
- 2 decks · latest Dec 13, 2017
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Analyst and Investor Meeting, ASH 2017 | Conference | 41 slides | Dec 13, 2017 |
| IPO Roadshow (May 2013) | IPO roadshow | 33 slides | May 7, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Kenneth Hoberman Other companies: Nuvectis Pharma, Inc. (Director · Since at least Feb 8, 2022); TG Therapeutics, Inc. (Chief Operating Officer and Corporate Secretary · Since at least Jun 26, 2018) | Chief Operating Officer · Dec 15, 2017 – Jun 10, 2020 · Past |
| Ron Bentsur Other companies: Nuvectis Pharma, Inc. (Chairman & CEO, Director · Since at least Feb 4, 2022); Beyond Air, Inc. (Director · Jul 27, 2020 – Nov 22, 2024 · Past) | Director · Jun 25, 2019 – Jun 10, 2020 · Past |
| Alan S Forman Other companies: JBG Smith Properties (Director · Since at least May 2, 2019) | Director · Jun 25, 2019 – Jun 10, 2020 · Past |
| David Gionco Other companies: Savient Pharmaceuticals Inc (Chief Accounting Officer · Feb 12, 2009 – Oct 15, 2013 · Past) | Chief Accounting Officer · Jan 16, 2014 – Jun 10, 2020 · Past |
| Robert Francomano Other companies: SELLAS Life Sciences Group, Inc. (Chief Commercial Officer · Mar 14, 2022 – Jan 22, 2024 · Past) | Chief Commercial Officer · Dec 6, 2019 – Jun 10, 2020 · Past |
Log in to ask 6ix AI your own questions about Stemline Therapeutics Inc.